IL75569A - 7alpha-alkanoylthio-9alpha-,11alphaepoxy steroids of the 20-spiroxane series,their manufacture and pharmaceutical compositions containing them - Google Patents

7alpha-alkanoylthio-9alpha-,11alphaepoxy steroids of the 20-spiroxane series,their manufacture and pharmaceutical compositions containing them

Info

Publication number
IL75569A
IL75569A IL75569A IL7556985A IL75569A IL 75569 A IL75569 A IL 75569A IL 75569 A IL75569 A IL 75569A IL 7556985 A IL7556985 A IL 7556985A IL 75569 A IL75569 A IL 75569A
Authority
IL
Israel
Prior art keywords
9alpha
7alpha
alkanoylthio
steroids
manufacture
Prior art date
Application number
IL75569A
Other versions
IL75569A0 (en
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of IL75569A0 publication Critical patent/IL75569A0/en
Publication of IL75569A publication Critical patent/IL75569A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • C07J53/0043 membered carbocyclic rings
    • C07J53/0083 membered carbocyclic rings in position 15/16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL75569A 1984-06-21 1985-06-19 7alpha-alkanoylthio-9alpha-,11alphaepoxy steroids of the 20-spiroxane series,their manufacture and pharmaceutical compositions containing them IL75569A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH300984 1984-06-21
CH464684 1984-09-28

Publications (2)

Publication Number Publication Date
IL75569A0 IL75569A0 (en) 1985-10-31
IL75569A true IL75569A (en) 1989-03-31

Family

ID=25691934

Family Applications (1)

Application Number Title Priority Date Filing Date
IL75569A IL75569A (en) 1984-06-21 1985-06-19 7alpha-alkanoylthio-9alpha-,11alphaepoxy steroids of the 20-spiroxane series,their manufacture and pharmaceutical compositions containing them

Country Status (16)

Country Link
US (1) US4670551A (en)
EP (1) EP0165902B1 (en)
AR (2) AR242036A1 (en)
AU (1) AU582754B2 (en)
CA (1) CA1239388A (en)
DE (1) DE3569540D1 (en)
DK (1) DK173854B1 (en)
ES (2) ES8704967A1 (en)
FI (1) FI83225C (en)
GR (1) GR851499B (en)
HU (1) HU192232B (en)
IE (1) IE58050B1 (en)
IL (1) IL75569A (en)
NO (1) NO165496C (en)
NZ (1) NZ212492A (en)
PT (1) PT80663B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69637140T2 (en) 1995-12-11 2008-04-10 G.D. Searle Llc, Chicago PROCESS FOR PREPARING AN EPOXY COMPOUND
US6887991B1 (en) 1996-12-11 2005-05-03 G. D. Searle & Company Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein
EP1223174A3 (en) * 1996-12-11 2005-03-16 G.D. Searle & Co. Processes for preparation of 3-keto-7alpha-alkoxycarbonyl-delta-4,5- steroids and intermediates useful therein
NZ336004A (en) 1996-12-11 2001-04-27 G Process for preparation of 3-keto-7-alpha-alkoxycarbonyl substituted delta-4,5-steroid by reacting 4,5-dihydro-5,7-lactone steroid substrate in the presence of a base
CA2330611A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
PL371128A1 (en) 2001-12-12 2005-06-13 Pharmacia Corporation Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists
US7235655B2 (en) 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
WO2007025780A2 (en) * 2005-09-02 2007-03-08 Recordati Ireland Limited Aldosterone receptor antagonists
JP2009508494A (en) 2005-09-16 2009-03-05 ラプトール ファーマシューティカル インコーポレイテッド Compositions comprising receptor-binding protein (RAP) variants specific for proteins comprising CR and uses thereof
HUE059078T2 (en) 2009-02-20 2022-10-28 Enhanx Biopharm Inc Glutathione-based drug delivery system
JP2012526144A (en) 2009-05-06 2012-10-25 ラボラトリー スキン ケア インコーポレイテッド Transdermal delivery composition comprising active substance-calcium phosphate particle complex and method of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3013012A (en) * 1960-12-22 1961-12-12 Searle & Co Alkanoylthio-17alpha-carboxyethyl-17beta-hydroxyandrosten-3-one lactones
US3095412A (en) * 1961-12-19 1963-06-25 Searle & Co 9alpha, 11alpha-epoxy and 11beta-chloro-9alpha-hydroxy 17alpha-(2-carboxyethyl)-17beta-hydroxyandrost-4-en-3-one gamma-lactones and delta1 and delta6 analogs
GB1041534A (en) * 1963-04-24 1966-09-07 Merck & Co Inc 20-spiroxane compounds
DE2652761C2 (en) * 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-methylene-spirolactones, processes for their preparation and pharmaceuticals containing them
US4559332A (en) * 1983-04-13 1985-12-17 Ciba Geigy Corporation 20-Spiroxanes and analogues having an open ring E, processes for their manufacture, and pharmaceutical preparations thereof
EP0134529B1 (en) * 1983-08-17 1990-03-21 Schering Aktiengesellschaft 7-alpha-substituted 3-oxo-17-alpha-pregn-4-ene 21-17 carbolactones, process for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
FI83225C (en) 1991-06-10
IE851535L (en) 1985-12-21
PT80663B (en) 1987-05-08
NO852501L (en) 1985-12-23
HU192232B (en) 1987-05-28
EP0165902A3 (en) 1986-10-22
ES544387A0 (en) 1987-04-16
AR245731A1 (en) 1994-02-28
ES8704967A1 (en) 1987-04-16
IE58050B1 (en) 1993-06-16
HUT38367A (en) 1986-05-28
EP0165902B1 (en) 1989-04-19
GR851499B (en) 1985-11-25
FI83225B (en) 1991-02-28
US4670551A (en) 1987-06-02
NO165496B (en) 1990-11-12
ES8707737A1 (en) 1987-08-16
DE3569540D1 (en) 1989-05-24
FI852430L (en) 1985-12-22
AU4397185A (en) 1986-01-02
FI852430A0 (en) 1985-06-19
AR242036A1 (en) 1993-02-26
ES557112A0 (en) 1987-08-16
IL75569A0 (en) 1985-10-31
DK280085D0 (en) 1985-06-20
NZ212492A (en) 1989-02-24
PT80663A (en) 1985-07-01
DK173854B1 (en) 2001-12-27
EP0165902A2 (en) 1985-12-27
NO165496C (en) 1991-02-20
CA1239388A (en) 1988-07-19
AU582754B2 (en) 1989-04-13
DK280085A (en) 1985-12-22

Similar Documents

Publication Publication Date Title
IL77004A0 (en) 5-amino-4-hydroxyvaleryl derivatives,their manufacture and pharmaceutical compositions containing them
IL65056A0 (en) Imidazodiazepines,their manufacture and pharmaceutical compositions containing them
IL67920A0 (en) New derivatives of 3-keto delta 4,9,19-nor steroids,their preparation,their application as medicaments,the compositions containing them and the new intermediates obtained
IL79336A (en) Substituted androsta-1,4-diene-3,17-diones,their preparation and pharmaceutical compositions containing them
IL60474A (en) Cyclopeptides of the somatostatin type,their manufacture and pharmaceutical compositions containing them
PH22420A (en) 5h-2,3-benzodiozepine derivatives and pharmaceutical compositions containing the same
IL72725A0 (en) Steroids,their manufacture and pharmaceutical compositions containing them
IL75569A (en) 7alpha-alkanoylthio-9alpha-,11alphaepoxy steroids of the 20-spiroxane series,their manufacture and pharmaceutical compositions containing them
IL77052A (en) Hexafluoro-1alpha,25-dihydroxy-cholecalciferol derivatives,their preparation and pharmaceutical compositions containing them
IL66618A0 (en) Imidazoquinazoline derivatives,their manufacture and pharmaceutical compositions containing them
IL81164A0 (en) Aminoglycosides of steroids,their preparation and pharmaceutical compositions containing them
IL67284A (en) N-substituted-2-pyridylindoles,their manufacture and pharmaceutical compositions containing them
IL75966A0 (en) 3-substituted-1-aminoalkyl-1h-indoles,their preparation and pharmaceutical compositions containing them
PT79858B (en) Process for the preparation of azolyl-aryl-alcanol and pharmaceutical compositions therewith
IL96366A0 (en) Steroids,their manufacture and pharmaceutical compositions containing them
IL76312A (en) Xenocoumacins and derivatives thereof,their preparation and pharmaceutical compositions containing them
DE3573784D1 (en) Carboxyalkyldipeptides, their preparation and pharmaceutical compositions containing them
DE3561808D1 (en) Phenylnonatetraenic-acid derivatives, their preparation and pharmaceutical compositions containing them
IL68619A0 (en) Quinazoline derivatives,their manufacture and pharmaceutical compositions containing them
ZA836538B (en) Dichloro derivatives of the 16alpha-methyl pregnane series,their preparation,their use as medicaments and the compositions containing them
IL78957A (en) 11-beta substituted steroids,their preparation and pharmaceutical compositions containing them
PH21779A (en) Sulfonomidines and pharmaceutical compositions containing the same
IL70873A0 (en) D-homosteroids,their manufacture and pharmaceutical compositions containing them
IL56494A (en) 17 alpha-alkoxyalkoxy steroids of the pregnane series,their preparation and pharmaceutical compositions containing them
PT79990B (en) Process for the preparation of diazepine-indoles and of pharmaceutical compositions therewith

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)
KB Patent renewed
RH1 Patent not in force